Ceribell (CBLL) Income from Continuing Operations (2023 - 2026)
Ceribell (CBLL) reported Income from Continuing Operations of 19737000.0 for Q1 2026, down 54.47% on a YoY basis from 43352183.08 in Q1 2025, and down 45.91% quarter-over-quarter from 13527000.0 in Q4 2025.
Ceribell (CBLL) Income from Continuing Operations (2023 - 2026) Analysis & Trends
Ceribell has reported Income from Continuing Operations for 4 years, with the latest figure at 19737000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 54.47% year-over-year to 19737000.0; the trailing twelve-month figure through Mar 2026 stood at 60372000.0 (down 35.03% YoY), and the FY2025 full-year result was 53412000.0, down 32.03% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 19737000.0, down from 13527000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 7054000.0 in Q3 2023, with the low at 19737000.0 in Q1 2026.
- Historically, Income from Continuing Operations has averaged 11721090.91 across 4 years, with a median of 12576000.0 in 2024.
- Annual changes were most pronounced in 2025 — Income from Continuing Operations slipped 7.56% — and 2026, when it tumbled 54.47%.
- Ceribell's Income from Continuing Operations stood at 8274000.0 in 2023, then sank by 51.99% to 12576000.0 in 2024, then decreased by 7.56% to 13527000.0 in 2025, then slumped by 45.91% to 19737000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 19737000.0 (Q1 2026), 13527000.0 (Q4 2025), and 13465000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Ceribell | 679.82 Mn | 538.64 Mn | 23.12 Mn | -19.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.74 Mn |
| Dec 31, 2025 | -13.53 Mn |
| Sep 30, 2025 | -13.47 Mn |
| Jun 30, 2025 | -13.64 Mn |
| Mar 31, 2025 | -12.78 Mn |
| Dec 31, 2024 | -12.58 Mn |
| Sep 30, 2024 | -10.42 Mn |
| Jun 30, 2024 | -8.94 Mn |
| Mar 31, 2024 | -8.52 Mn |
| Dec 31, 2023 | -8.27 Mn |
| Sep 30, 2023 | -7.05 Mn |